OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Biosimilar Drugs for Psoriasis: Principles, Present, and Near Future
J.M. Carrascosa, Ira Jacobs, Danielle Petersel, et al.
Dermatology and Therapy (2018) Vol. 8, Iss. 2, pp. 173-194
Open Access | Times Cited: 56
J.M. Carrascosa, Ira Jacobs, Danielle Petersel, et al.
Dermatology and Therapy (2018) Vol. 8, Iss. 2, pp. 173-194
Open Access | Times Cited: 56
Showing 26-50 of 56 citing articles:
Recent Advancements in Novel Formulations of Anti-psoriatic Agents for Effective Delivery: Clinical Importance and Patent Survey
Nikhil Dadwal, Balak Das Kurmi, Dilpreet Singh, et al.
Recent Patents on Nanotechnology (2023) Vol. 18, Iss. 3, pp. 259-277
Closed Access | Times Cited: 5
Nikhil Dadwal, Balak Das Kurmi, Dilpreet Singh, et al.
Recent Patents on Nanotechnology (2023) Vol. 18, Iss. 3, pp. 259-277
Closed Access | Times Cited: 5
Targeting p19 as a treatment option for psoriasis: an evidence-based review of guselkumab
Todd Wechter, Abigail Cline, Steven R. Feldman
Therapeutics and Clinical Risk Management (2018) Vol. Volume 14, pp. 1489-1497
Open Access | Times Cited: 16
Todd Wechter, Abigail Cline, Steven R. Feldman
Therapeutics and Clinical Risk Management (2018) Vol. Volume 14, pp. 1489-1497
Open Access | Times Cited: 16
Reinforcing involvement of NK cells in psoriasiform dermatitis animal model
Mihaela Surcel, Adriana Munteanu, Radu‐Ionuț Huică, et al.
Experimental and Therapeutic Medicine (2019)
Open Access | Times Cited: 14
Mihaela Surcel, Adriana Munteanu, Radu‐Ionuț Huică, et al.
Experimental and Therapeutic Medicine (2019)
Open Access | Times Cited: 14
The future landscape of biosimilars in rheumatology: Where we are where we are going
Morton Scheinberg, Valdeŕilio Feijó Azevedo
Autoimmunity Reviews (2018) Vol. 18, Iss. 2, pp. 203-208
Closed Access | Times Cited: 12
Morton Scheinberg, Valdeŕilio Feijó Azevedo
Autoimmunity Reviews (2018) Vol. 18, Iss. 2, pp. 203-208
Closed Access | Times Cited: 12
The Use of TNFα Inhibitors in Treating Pediatric Skin Disorders
Quoc‐Bao D. Nguyen, Caroline T. Starling, Adelaide A. Hebert
Pediatric Drugs (2020) Vol. 22, Iss. 3, pp. 311-319
Closed Access | Times Cited: 11
Quoc‐Bao D. Nguyen, Caroline T. Starling, Adelaide A. Hebert
Pediatric Drugs (2020) Vol. 22, Iss. 3, pp. 311-319
Closed Access | Times Cited: 11
Disparities and barriers to the access of biologics in moderate‐to‐severe adult psoriasis
Vincent Wan, Alireza Habibi, Lorena Alexandra Mija, et al.
International Journal of Dermatology (2024)
Open Access | Times Cited: 1
Vincent Wan, Alireza Habibi, Lorena Alexandra Mija, et al.
International Journal of Dermatology (2024)
Open Access | Times Cited: 1
A Randomized, Double-Blind, Parallel-Group Phase I Study Comparing the Pharmacokinetics, Safety, and Immunogenicity of CMAB015, a Candidate Secukinumab Biosimilar, with Its Reference Product Cosentyx® in Healthy Chinese Male Subjects
Feng Yao, Chenguang Wang, Jie Ding, et al.
Drug Design Development and Therapy (2024) Vol. Volume 18, pp. 3891-3901
Open Access | Times Cited: 1
Feng Yao, Chenguang Wang, Jie Ding, et al.
Drug Design Development and Therapy (2024) Vol. Volume 18, pp. 3891-3901
Open Access | Times Cited: 1
Biosimilars for the treatment of patients with psoriasis: A consensus statement from the Biosimilar Working Group of the International Psoriasis Council
Arnon D. Cohen, Ronald Vender, Luigi Naldi, et al.
JAAD International (2020) Vol. 1, Iss. 2, pp. 224-230
Open Access | Times Cited: 10
Arnon D. Cohen, Ronald Vender, Luigi Naldi, et al.
JAAD International (2020) Vol. 1, Iss. 2, pp. 224-230
Open Access | Times Cited: 10
Biosimilares en el tratamiento de la psoriasis. Actualización
L. Puig, J.M. Carrascosa, J. Notario
Actas Dermo-Sifiliográficas (2020) Vol. 111, Iss. 10, pp. 809-814
Open Access | Times Cited: 9
L. Puig, J.M. Carrascosa, J. Notario
Actas Dermo-Sifiliográficas (2020) Vol. 111, Iss. 10, pp. 809-814
Open Access | Times Cited: 9
Criteria used to define tumor necrosis factor-alpha inhibitors failure in patients with moderate-to-severe psoriasis: a systematic literature review
I. Belinchón, Almudena Mateu Puchades, Miguel Ribera Pibernat, et al.
Annals of Medicine (2023) Vol. 55, Iss. 1, pp. 1335-1345
Open Access | Times Cited: 3
I. Belinchón, Almudena Mateu Puchades, Miguel Ribera Pibernat, et al.
Annals of Medicine (2023) Vol. 55, Iss. 1, pp. 1335-1345
Open Access | Times Cited: 3
Are biosimilars approved for use in psoriasis safe enough to replace leading biologic therapies? A review
Kelly A. Reynolds, Deeti J. Pithadia, Erica B. Lee, et al.
Expert Opinion on Drug Safety (2020) Vol. 19, Iss. 4, pp. 459-466
Closed Access | Times Cited: 8
Kelly A. Reynolds, Deeti J. Pithadia, Erica B. Lee, et al.
Expert Opinion on Drug Safety (2020) Vol. 19, Iss. 4, pp. 459-466
Closed Access | Times Cited: 8
Drug survival of adalimumab biosimilars in real‐world treatment of psoriasis: A S panish multicenter study
A. López‐Ferrer, Eva Vilarrasa, Susana Armesto, et al.
Dermatologic Therapy (2022) Vol. 35, Iss. 11
Closed Access | Times Cited: 5
A. López‐Ferrer, Eva Vilarrasa, Susana Armesto, et al.
Dermatologic Therapy (2022) Vol. 35, Iss. 11
Closed Access | Times Cited: 5
A Real-World Evaluation of the Long-Term Safety and Efficacy of Infliximab in the Treatment Moderate-to-Severe Psoriasis
Emily Haque, Aaminah Azhar, John Corbett, et al.
Dermatology and Therapy (2020) Vol. 10, Iss. 5, pp. 1121-1135
Open Access | Times Cited: 5
Emily Haque, Aaminah Azhar, John Corbett, et al.
Dermatology and Therapy (2020) Vol. 10, Iss. 5, pp. 1121-1135
Open Access | Times Cited: 5
Long-term safety and efficacy of anti-tumor necrosis factor-alpha biosimilar agents in the treatment of psoriasis: a single center study
Federica Ricceri, Elia Rosi, Antonella Di Cesare, et al.
Journal of Dermatological Treatment (2021) Vol. 33, Iss. 4, pp. 1983-1985
Closed Access | Times Cited: 5
Federica Ricceri, Elia Rosi, Antonella Di Cesare, et al.
Journal of Dermatological Treatment (2021) Vol. 33, Iss. 4, pp. 1983-1985
Closed Access | Times Cited: 5
A case of pediatric acrodermatitis continua of Hallopeau successfully treated with adalimumab biosimilar
Matteo Megna, Gabriella Fabbrocini, Cláudia Costa, et al.
Dermatologic Therapy (2020) Vol. 33, Iss. 3
Open Access | Times Cited: 4
Matteo Megna, Gabriella Fabbrocini, Cláudia Costa, et al.
Dermatologic Therapy (2020) Vol. 33, Iss. 3
Open Access | Times Cited: 4
Effectiveness, survival and safety of guselkumab attending to basal characteristics in moderate-to-severe psoriatic patients: a cohort study
Ricardo Ruíz‐Villaverde, Lourdes Rodriguez‐Fernandez‐Freire, José Carlos Armario Hita, et al.
F1000Research (2022) Vol. 11, pp. 1178-1178
Open Access | Times Cited: 3
Ricardo Ruíz‐Villaverde, Lourdes Rodriguez‐Fernandez‐Freire, José Carlos Armario Hita, et al.
F1000Research (2022) Vol. 11, pp. 1178-1178
Open Access | Times Cited: 3
Biosimilars in the Treatment of Psoriasis: An Update
L. Puig, J.M. Carrascosa, J. Notario
Actas Dermo-Sifiliográficas (2020) Vol. 111, Iss. 10, pp. 809-814
Open Access | Times Cited: 3
L. Puig, J.M. Carrascosa, J. Notario
Actas Dermo-Sifiliográficas (2020) Vol. 111, Iss. 10, pp. 809-814
Open Access | Times Cited: 3
Efficacy of Biosimilars in Psoriasis
Michael Tyutyunik, Grace W. Kimmel
Journal of Psoriasis and Psoriatic Arthritis (2019) Vol. 4, Iss. 2, pp. 67-69
Closed Access | Times Cited: 2
Michael Tyutyunik, Grace W. Kimmel
Journal of Psoriasis and Psoriatic Arthritis (2019) Vol. 4, Iss. 2, pp. 67-69
Closed Access | Times Cited: 2
Reassurance Techniques Do Not Significantly Impact Confidence in Biosimilars for Psoriasis: A Survey of a Convenience Sample of Individuals with Self-Identified Psoriasis
Matthew L. Hrin, Jeremy K. Bray, Steven R. Feldman
Dermatology and Therapy (2022) Vol. 12, Iss. 9, pp. 2173-2180
Open Access | Times Cited: 2
Matthew L. Hrin, Jeremy K. Bray, Steven R. Feldman
Dermatology and Therapy (2022) Vol. 12, Iss. 9, pp. 2173-2180
Open Access | Times Cited: 2
Effectiveness, survival and safety of guselkumab attending to basal characteristics in moderate-to-severe psoriatic patients: a cohort study
Ricardo Ruíz‐Villaverde, Lourdes Rodriguez‐Fernandez‐Freire, José Carlos Armario Hita, et al.
F1000Research (2022) Vol. 11, pp. 1178-1178
Open Access | Times Cited: 2
Ricardo Ruíz‐Villaverde, Lourdes Rodriguez‐Fernandez‐Freire, José Carlos Armario Hita, et al.
F1000Research (2022) Vol. 11, pp. 1178-1178
Open Access | Times Cited: 2
Production of an anti-TNFα antibody in murine myeloma cells by perfusion culture
Alexi Bueno-Soler, Julio Palacios-Oliva, Denise Dorvignit-Pedroso, et al.
Applied Microbiology and Biotechnology (2022) Vol. 106, Iss. 13-16, pp. 5007-5021
Closed Access | Times Cited: 1
Alexi Bueno-Soler, Julio Palacios-Oliva, Denise Dorvignit-Pedroso, et al.
Applied Microbiology and Biotechnology (2022) Vol. 106, Iss. 13-16, pp. 5007-5021
Closed Access | Times Cited: 1
Effects of retinoic acid on immunity and inflammation in patients with <i>Psoriasis vulgaris</i>
Yi Liu, Min Li, Zhangjun Ding
Tropical Journal of Pharmaceutical Research (2023) Vol. 22, Iss. 7, pp. 1469-1474
Open Access
Yi Liu, Min Li, Zhangjun Ding
Tropical Journal of Pharmaceutical Research (2023) Vol. 22, Iss. 7, pp. 1469-1474
Open Access
Estimation of patients with psoriasis potentially eligible and currently untreated with biological drugs in Italy
Luca Degli Esposti, Valentina Perrone, Melania Dovizio, et al.
Italian Journal of Dermatology and Venereology (2023) Vol. 158, Iss. 6
Closed Access
Luca Degli Esposti, Valentina Perrone, Melania Dovizio, et al.
Italian Journal of Dermatology and Venereology (2023) Vol. 158, Iss. 6
Closed Access
Biosimilars approved for psoriasis treatment in Europe
Ardea Milidrag, Maja Lačković, Ivana Dimić, et al.
PONS - medicinski casopis (2023) Vol. 20, Iss. 2, pp. 71-78
Open Access
Ardea Milidrag, Maja Lačković, Ivana Dimić, et al.
PONS - medicinski casopis (2023) Vol. 20, Iss. 2, pp. 71-78
Open Access
Safety and efficacy of Chinese herbal bath for psoriasis vulgaris
Wenxia Lin, Qianying Yu, Yuesi Qin, et al.
Medicine (2020) Vol. 99, Iss. 21, pp. e20488-e20488
Open Access
Wenxia Lin, Qianying Yu, Yuesi Qin, et al.
Medicine (2020) Vol. 99, Iss. 21, pp. e20488-e20488
Open Access
